Skip Navigation

Cardiovascular Research 2001 51(2):322-330; doi:10.1016/S0008-6363(01)00287-5
© 2001 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Forini, F.
Right arrow Articles by Iervasi, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Forini, F.
Right arrow Articles by Iervasi, G.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2000, European Society of Cardiology

3,5,3'-Triiodothyronine deprivation affects phenotype and intracellular [Ca2+]i of human cardiomyocytes in culture

Francesca Forinia, Aldo Paolicchib, Tommaso Pizzorussoc, Gian Michele Rattod, Michela Saviozzib, Vittorio Vaninie and Giorgio Iervasia,*

aIstituto di Fisiologia Clinica C.N.R., via Moruzzi 1, 56100 Pisa, Italy
bDipartimento di Patologia Sperimentale, Università di Pisa, Pisa, Italy
cScuola Normale Superiore, Pisa, Italy
dIstituto di Neurofisiologia C.N.R., Pisa, Italy
eOspedale Pediatrico Apuano, Divisione di Cardiochirurgia C.N.R., Massa, Italy

simona{at}ifc.cnr.it

paolicchi{at}biomed.unipi.it

tommaso{at}in.pi.cnr.it

gimmi{at}in.pi.cnr.it

saviozzim{at}biomed.unipi.it

anest{at}ifc.pi.cnr.it

iervasi{at}ifc.cnr.it

* Corresponding author. Tel.: +39-50-3152216; fax: +39-50-3152166

Objective: A decrease in plasma T3 concentration is a frequent finding in patients with heart failure. However, the role of this ‘low T3 syndrome’ on disease evolution has never been clarified. As phenotypic and functional cardiomyocyte impairments are alterations that correlate with the failing myocardium, we studied the long-term effects of T3 deprivation on human cardiomyocyte structure and calcium handling. Methods: Atrial cardiomyocytes and myocardial tissue were cultured with or without 3 nM T3. Microscopical examination of structural features was followed by analysis of {alpha}-sarcomeric actinin and sarcoplasmic reticulum calcium ATP-ase (SERCA-2) content. Calcium handling was studied by [Ca2+]i imaging. Results: When stimulated with cyclopiazonic acid, a SERCA-2 inhibitor, T3-deprived cardiomyocytes showed significantly faster (P=0.03) and more transient (P=0.04) increases in [Ca2+]i than T3-supplemented cells. Moreover, in the T3-free cultures a significantly lower number of cells (P=0.003) responded to caffeine, a typical activator of sarcoplasmic reticulum Ca2+-release channel. T3-deprived cardiomyocytes also presented altered morphology with larger dimensions than T3-supplemented cells (P<0.0001). Additionally, in T3-deprived samples {alpha}-sarcomeric actinin and SERCA-2 protein levels were reduced to 65.6±3% (P<0.0001) and 74.1±4% (P=0.005), respectively, when compared with the T3-supplemented group. Conclusions: Our data show that human cardiomyocyte calcium handling and phenotype are strongly influenced by T3 suggesting important implications of the ‘low T3 syndrome’ on the progression of heart failure.

KEYWORDS Cell culture/isolation; Myocytes; Hormones; Calcium (cellular); SR-function; Heart failure


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Eur J EndocrinolHome page
S. J. Lee, J. G. Kang, O. H. Ryu, C. S. Kim, S.-H. Ihm, M. G. Choi, H. J. Yoo, and K. S. Hong
The relationship of thyroid hormone status with myocardial function in stress cardiomyopathy
Eur. J. Endocrinol., May 1, 2009; 160(5): 799 - 806.
[Abstract] [Full Text] [PDF]


Home page
Eur J Heart FailHome page
G. Kozdag, D. Ural, A. Vural, A. Agacdiken, G. Kahraman, T. Sahin, E. Ural, and B. Komsuoglu
Relation between free triiodothyronine/free thyroxine ratio, echocardiographic parameters and mortality in dilated cardiomyopathy
Eur J Heart Fail, January 1, 2005; 7(1): 113 - 118.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
A. G. Cerillo, S. Bevilacqua, S. Storti, M. Mariani, E. Kallushi, A. Ripoli, A. Clerico, and M. Glauber
Free triiodothyronine: a novel predictor of postoperative atrial fibrillation
Eur. J. Cardiothorac. Surg., October 1, 2003; 24(4): 487 - 492.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S.D. Bird, P.A. Doevendans, M.A. van Rooijen, A. Brutel de la Riviere, R.J. Hassink, R. Passier, and C.L. Mummery
The human adult cardiomyocyte phenotype
Cardiovasc Res, May 1, 2003; 58(2): 423 - 434.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
G. Iervasi, A. Pingitore, P. Landi, M. Raciti, A. Ripoli, M. Scarlattini, A. L'Abbate, and L. Donato
Low-T3 Syndrome: A Strong Prognostic Predictor of Death in Patients With Heart Disease
Circulation, February 11, 2003; 107(5): 708 - 713.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.